Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer

PURPOSE: Valid determination of HER2 status is a prerequisite to establish an adequate treatment strategy for breast cancer patients, regardless of the disease stage. The goal of this study was to examine the feasibility of the newly developed silver-enhanced in situ hybridization (SISH) technique a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Park, Kyeongmee, Han, Sehwan, Kim, Jung-Yeon, Kim, Hyun-Jung, Kwon, Ji Eun, Gwak, Geumhee
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Breast Cancer Society 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3268923/
https://ncbi.nlm.nih.gov/pubmed/22323913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2011.14.4.276
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky